230 related articles for article (PubMed ID: 24705154)
21. Estimation of radiation-induced secondary cancer risks for early-stage non-small cell lung cancer patients after stereotactic body radiation therapy.
Han C; Schultheiss TE; Wong JYC
Pract Radiat Oncol; 2017; 7(3):e185-e194. PubMed ID: 28089479
[TBL] [Abstract][Full Text] [Related]
22. Evaluations of secondary cancer risk in spine radiotherapy using 3DCRT, IMRT, and VMAT: A phantom study.
Rehman Ju; Tailor RC; Isa M; Afzal M; Chow J; Ibbott GS
Med Dosim; 2015; 40(1):70-5. PubMed ID: 25434808
[TBL] [Abstract][Full Text] [Related]
23. Pediatric Cranio-spinal Axis Irradiation: Comparison of Radiation-induced Secondary Malignancy Estimations Based on Three Methods of Analysis for Three Different Treatment Modalities.
Myers PA; Mavroidis P; Komisopoulos G; Papanikolaou N; Stathakis S
Technol Cancer Res Treat; 2015 Apr; 14(2):169-80. PubMed ID: 24684581
[TBL] [Abstract][Full Text] [Related]
24. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
25. A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer.
Joosten A; Bochud F; Moeckli R
Phys Med Biol; 2014 Aug; 59(16):4697-722. PubMed ID: 25082795
[TBL] [Abstract][Full Text] [Related]
26. Propensity-score-matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with IMRT/VMAT.
Chao PJ; Lee HF; Lan JH; Guo SS; Ting HM; Huang YJ; Chen HC; Lee TF
Sci Rep; 2017 Oct; 7(1):13771. PubMed ID: 29062118
[TBL] [Abstract][Full Text] [Related]
27. Minimising contralateral breast dose in post-mastectomy intensity-modulated radiotherapy by incorporating conformal electron irradiation.
van der Laan HP; Korevaar EW; Dolsma WV; Maduro JH; Langendijk JA
Radiother Oncol; 2010 Feb; 94(2):235-40. PubMed ID: 20080312
[TBL] [Abstract][Full Text] [Related]
28. Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes.
Zwahlen DR; Bischoff LI; Gruber G; Sumila M; Schneider U
Radiat Oncol; 2016 Nov; 11(1):149. PubMed ID: 27832799
[TBL] [Abstract][Full Text] [Related]
29. Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease : Effects of modern radiotherapy techniques.
Corradini S; Ballhausen H; Weingandt H; Freislederer P; Schönecker S; Niyazi M; Simonetto C; Eidemüller M; Ganswindt U; Belka C
Strahlenther Onkol; 2018 Mar; 194(3):196-205. PubMed ID: 28916844
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric Comparison of Intensity-Modulated Radiotherapy, Volumetric Modulated Arc Therapy and Hybrid Three-Dimensional Conformal Radiotherapy/Intensity-Modulated Radiotherapy Techniques for Right Breast Cancer.
Liu YC; Chang HM; Lin HH; Lu CC; Lai LH
J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33260404
[TBL] [Abstract][Full Text] [Related]
31. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies.
Ruben JD; Davis S; Evans C; Jones P; Gagliardi F; Haynes M; Hunter A
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1530-6. PubMed ID: 18207670
[TBL] [Abstract][Full Text] [Related]
32. Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy.
Simonetto C; Rennau H; Remmele J; Sebb S; Kundrát P; Eidemüller M; Wolf U; Hildebrandt G
Strahlenther Onkol; 2019 Jan; 195(1):32-42. PubMed ID: 30350118
[TBL] [Abstract][Full Text] [Related]
33. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
[TBL] [Abstract][Full Text] [Related]
34. Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer.
Cilla S; Macchia G; Sabatino D; Digesù C; Deodato F; Piermattei A; De Spirito M; Morganti AG
Med Dosim; 2013; 38(1):5-11. PubMed ID: 22727549
[TBL] [Abstract][Full Text] [Related]
35. Multisegmented tangential breast fields: a rational way to treat breast cancer.
Gulybán A; Kovács P; Sebestyén Z; Farkas R; Csere T; Karácsonyi G; Dérczy K; Hideghéty K; Esik O
Strahlenther Onkol; 2008 May; 184(5):262-9. PubMed ID: 18427757
[TBL] [Abstract][Full Text] [Related]
36. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.
Wong WW; Vora SA; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK
Cancer; 2009 Dec; 115(23):5596-606. PubMed ID: 19670452
[TBL] [Abstract][Full Text] [Related]
37. Dosimetric comparison of left-sided whole breast irradiation with 3D-CRT, IP-IMRT and hybrid IMRT.
Xie X; Ouyang S; Wang H; Yang W; Jin H; Hu B; Shen L
Oncol Rep; 2014 May; 31(5):2195-205. PubMed ID: 24604635
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of real-time couch tracking during 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, and volumetric modulated arc therapy for prostate cancer.
Wilbert J; Baier K; Hermann C; Flentje M; Guckenberger M
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):237-42. PubMed ID: 22541958
[TBL] [Abstract][Full Text] [Related]
39. Optimized dose coverage of regional lymph nodes in breast cancer: the role of intensity-modulated radiotherapy.
Dogan N; Cuttino L; Lloyd R; Bump EA; Arthur DW
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1238-50. PubMed ID: 17512134
[TBL] [Abstract][Full Text] [Related]
40. Breast radiotherapy in the prone position primarily reduces the maximum out-of-field measured dose to the ipsilateral lung.
Becker SJ; Elliston C; Dewyngaert K; Jozsef G; Brenner D; Formenti S
Med Phys; 2012 May; 39(5):2417-23. PubMed ID: 22559611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
